Bacterial infiltration and bioprosthetic valve failure: Emerging diagnostics for emerging therapies

Alexander P Kossar; Isaac George; Rachel Gordon; Giovanni Ferrari

doi:10.1016/j.jtcvs.2019.07.149

Bacterial infiltration and bioprosthetic valve failure: Emerging diagnostics for emerging therapies

J Thorac Cardiovasc Surg. 2020 Apr;159(4):1279-1282. doi: 10.1016/j.jtcvs.2019.07.149. Epub 2019 Oct 25.

Authors

Alexander P Kossar¹, Isaac George¹, Rachel Gordon², Giovanni Ferrari³

Affiliations

¹ Division of Cardiothoracic Surgery, Department of Surgery, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY.
² Division of Infectious Diseases, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY.
³ Division of Cardiothoracic Surgery, Department of Surgery, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY. Electronic address: gf2375@cumc.columbia.edu.

Abstract

Profile (A) and inflow surface (B) of an explanted TAVR bioprosthesis with structural degeneration and endocarditis (reprinted with permission from Seeburger and colleagues).

Bacterial infiltration and bioprosthetic valve failure: Emerging diagnostics for emerging therapies

Authors

Affiliations

Abstract

Publication types

MeSH terms

Grants and funding